pharmaceutical mergers and acquisitions

Mankind Pharma BSV acquisition strategic deal in the biotech industry

Mankind Pharma BSV Acquisition: Game-Changing ₹9,000 Crore Investment Set to Elevate Biotech Sector

by Megan Wood
September 3, 2024September 3, 2024

Explore the strategic Mankind Pharma BSV acquisition valued at ₹9,000 crore, a move set to revolutionize the biotech industry and elevate Mankind Pharma’s global presence.